Evidence map›Paper›PMID 30200379›Full record

ReviewHigh-throughput2018

Oral Biofilms: Development, Control, and Analysis.

Daniela Berger, Aviva Rakhamimova, Andrew Pollack, Zvi Loewy

Open access · goldAbstract readReview
In one paragraph

Review in High-throughput, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 3 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 3 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Key virulence genes associated withFrontiers in oral health · 2025
    Pooled it
  3. Pooled it
  4. IsGut microbes · 2026
    Review
  5. Article
  6. The redefined identity ofJournal of bacteriology · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Journal of experimental pharmacology · 2025
    Article
  14. Microorganisms · 2024
    Review
  15. Review
  16. Probiotic Effect ofPathogens (Basel, Switzerland) · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniela BergerDepartment of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, NY 10027, USA. dberger@student.touro.edu.
Aviva RakhamimovaDepartment of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, NY 10027, USA. arakhami2@student.touro.edu.
Andrew PollackDepartment of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, NY 10027, USA. apollack5@student.touro.edu.
Zvi LoewyDepartment of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, NY 10027, USA. zvi.loewy@touro.edu.
Touro College · USNew York Medical College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oral cavity harbors hundreds of microbial species that are present either as planktonic cells or incorporated into biofilms. The majority of the oral microbes are commensal organisms. Those that are pathogenic microbes can result in oral infections, and at times can initiate systemic diseases. Biofilms that contain pathogens are challenging to control. Many conventional antimicrobials have proven to be ineffective. Recent advances in science and technology are providing new approaches for pathogen control and containment and methods to characterize biofilms. This perspective provides (1) a general understanding of biofilm development; (2) a description of emerging chemical and biological methods to control oral biofilms; and (3) an overview of high-throughput analytical approaches to analyze biofilms.

Indexed as

antimicrobialbiofilmhigh-throughput analysis

Identifiers

PMID30200379
PMCPMC6163956
OpenAlexW2886109114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.